UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________

FORM 8-K

_________________

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~April~~May 2812, 2026 ~~(April 24, 2026)~~

_______________________________

SOLESENCE, INC.

(Exact name of registrant as specified in its charter)

_______________________________

Delaware	~~000~~001-~~22333~~42589	36-3687863
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

1319 Marquette Drive

Romeoville, Illinois 60446

(Address of Principal Executive Offices) (Zip Code)

(630) 771-6708

(Registrant's telephone number, including area code)

(Former name or former address, if changed since last report)

_______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.01 par value per share	SLSN	The NASDAQ Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 52.02. ~~Departure~~Results of ~~Directors~~Operations orand ~~Certain~~Financial ~~Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers~~Condition.

~~Effective~~On ~~April~~May 2412, 2026, the ~~Board~~Registrant ofissued ~~Directors~~a ofpress ~~the~~release, ~~Company (the "Board") appointed Marc James to serve as~~ a ~~Class~~copy ~~II Director~~ of ~~the~~which ~~Board~~is ~~for~~attached ~~the~~hereto ~~remainder~~as ofExhibit ~~the term of Class II Directors of the Board, expiring at the 2026 Annual Meeting of Shareholders of the Company~~99.1 ~~Mr. James has been appointed to the following committees of the Board: Audit~~ and ~~Finance Committee,~~is ~~Compensation~~incorporated ~~Committee,~~herein ~~and~~by ~~Nominating and Corporate Governance Committee~~reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.


99.1		Press Release dated May 12, 2026
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

Exhibit No.		Description
99.1		Press Release dated April 27, 2026
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	SOLESENCE, INC.
Date: April 28, 2026	By:	/s/ Laura Riffner
Date: May 12, 2026	By:	/s/ Laura Riffner
		Laura Riffner
		Chief Financial Officer

Filing Compare · SOLESENCE, INC.